Skip to main content
Normal View

Medical Products

Dáil Éireann Debate, Tuesday - 22 September 2015

Tuesday, 22 September 2015

Questions (789)

Michael Healy-Rae

Question:

789. Deputy Michael Healy-Rae asked the Minister for Health the reason in most cases only limited information on the adverse drug reactions is provided to the Health Products Regulatory Authority in association with roaccutane since 1983; the other essential information concerning roaccutane that is withheld; by whom and the reason it is withheld; if he will provide details of same; and if he will make a statement on the matter. [30696/15]

View answer

Written answers

I refer the Deputy to my composite reply 26767/15 of 2 July which sets out all the available information relating to the reporting of adverse drug reactions.

Top
Share